HAMBURG, Germany, March 10, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) today announced the establishment of a research collaboration with Harvard University and the Howard Hughes Medical Institute (HHMI) aimed at discovering and developing new treatments in the field of diabetes.
